Cutaneous Nontuberculous Mycobacteria Infections Following Cosmetic Procedures: A Retrospective Study.

Infection and drug resistance 2025 Vol.18() p. 2301-2309

Zeng R, Xiong J, Gao W, Peng J, Shi Y, Zhang W, Jiang H, Cheng C, Ge G, Wang Z, Mei Y, Chen Z, Wang H

관련 도메인

Abstract

[BACKGROUND] Reports of skin infections associated with nontuberculous mycobacteria (NTM) following cosmetic procedures are increasing. The diagnosis and treatment of these infections remain a significant challenge for clinicians.

[OBJECTIVE] We examined the clinical characteristics, microbiology, histopathology, and treatment strategies of NTM infections following cosmetic procedures, including botulinum toxin injection, lipolysis injection, hyaluronic acid injection, mesotherapy, autologous fat grafting, and other related procedures.

[METHODS] This retrospective study of cosmetology-related cutaneous NTM infections diagnosed based on culture or molecular identification was conducted at a tertiary dermatology hospital in China. Demographic, clinical, microbiological, pathological biopsy, management, and outcome data were also collected.

[RESULTS] The series enrolled 28 patients, four diagnosed by molecular identification and histology, and 24 by positive culture. All 24 NTM cultures were rapid-growing mycobacteria, mainly complex (75%), with a mean time to positive culture of 11.8 days. The mean incubation period for the lesions was three weeks, while the mean time to diagnosis was 9.8 weeks. Treatment typically requires long-term, multi-drug therapy. Surgical intervention may shorten the disease course.

[CONCLUSION] Cosmetology-related cutaneous NTM infections are frequently underrecognized and challenging to diagnose, leading to delayed treatment. We aimed to enhance clinician awareness of NTM infections to facilitate early detection and prompt treatment. Empirical therapy with clarithromycin and moxifloxacin may be considered in the absence of susceptibility results, but treatment decisions should be carefully guided by susceptibility testing results. Surgical intervention may be beneficial, and tigecycline is a viable option when resistant to clarithromycin.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 1
해부 skin scispacy 1
해부 fat scispacy 1
합병증 lesions scispacy 1
재료 hyaluronic acid 히알루론산 dict 1
약물 NTM → nontuberculous mycobacteria C1265234
Nontuberculous Mycobacteria
scispacy 1
약물 NTM infections C3714514
Infection
scispacy 1
약물 lipolysis C0023796
Lipolysis
scispacy 1
약물 clarithromycin C0055856
clarithromycin
scispacy 1
약물 moxifloxacin C0536495
moxifloxacin
scispacy 1
약물 tigecycline C1260298
tigecycline
scispacy 1
약물 [BACKGROUND] scispacy 1
약물 [OBJECTIVE] scispacy 1
질환 Nontuberculous Mycobacteria Infections C0026919
Mycobacterium Infections, Nontuberculous
scispacy 1
질환 skin infections C0037278
Skin Diseases, Infectious
scispacy 1
질환 nontuberculous mycobacteria C1265234
Nontuberculous Mycobacteria
scispacy 1
질환 infections C0851162
Infections of musculoskeletal system
scispacy 1
질환 cosmetology-related cutaneous NTM infections scispacy 1
질환 NTM → nontuberculous mycobacteria scispacy 1
질환 cutaneous NTM scispacy 1
질환 disease scispacy 1
기타 patients scispacy 1

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문